Free Trial
NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

$21.01 -0.01 (-0.05%)
As of 01:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)

Key Stats

Today's Range
$20.93
$21.08
50-Day Range
$18.22
$22.43
52-Week Range
$13.42
$31.65
Volume
6,586 shs
Average Volume
47,599 shs
Market Capitalization
$14.71 million
Assets Under Management
$14.76 million
Dividend Yield
1.09%
Net Expense Ratio
0.79%
Aggregate Rating
Moderate Buy

ETF Overview

Virtus LifeSci Biotech Clinical Trials ETF Expenses

TypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.79%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.79%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.79%0.60%0.63%0.58%0.60%
Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

BBC ETF News Headlines

BBC Virtus LifeSci Biotech Clinical Trials ETF
Crypto bros: Meet your replacement
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.
Tech ETFs on the Rise After Four Weeks in Deep Red
See More Headlines

BBC ETF - Frequently Asked Questions

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $23.94 at the beginning of 2025. Since then, BBC stock has decreased by 12.2% and is now trading at $21.0090.

Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Clinical Trials ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), e.l.f. Beauty (ELF) and GE Aerospace (GE).

Fund Details

Issuer
Virtus
Fund Name
Virtus LifeSci Biotech Clinical Trials ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BBC
Inception Date
12/16/2014
Fund Manager
Matthew B. Brown, Seth Kadushin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci Biotechnology Clinical Trials Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
119

Fund Statistics

Assets Under Management
$14.76 million
Average Daily Volume
$43.81 thousand
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
Virtus ETF Solutions, LLC
Advisor
Virtus ETF Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ETF Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
6
Put Options
1
Call Options
6
Short Interest
5,700 shs

Miscellaneous

Beta
1.08
Creation Unit
50,000
Creation Fee
$500.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 10 BBC Holdings

BBC Sector Exposure

BBC Industry Exposure


This page (NYSEARCA:BBC) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners